• 1
    Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 1995; 45: 830.
  • 2
    American Cancer Society. Cancer facts and figures, 1998. Atlanta, GA: American Cancer Society, 1998.
  • 1
    SEER. Cancer statistics review, 1973–1994. SEER Available from URL: [accessed June 1, 2000].
  • 4
    RiesLAG, MillerBA, HankeyBF, KosaryCL, HarrasA, EdwardsBK, eds. SEER cancer statistics review, 1973–1991: table and graphs, 1994. Bethesda, MD: National Cancer Institute, 1994.
  • 5
    Ndubuisi SC, Kofie VY, Andoh JY, Schwartz EM. Black-white differences in the stage at presentation of prostate cancer in the District of Columbia. Urology 1995; 46: 7717.
  • 6
    Schwartz KL, Severson RK, Gurney JG, Montie JE. Trends in the stage-specific incidence of prostate carcinoma in the Detroit metropolitan area. Cancer 1996; 78: 12606.
  • 7
    Polednek AP, Flannery JP. Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut. Cancer 1992; 70: 21528.
  • 8
    Myers RE, Thomas WA, Balshem AM, Ross EA, Chodek GW. Receptivity of African-American men to prostate cancer screening. Urology 1996; 43: 4807.
  • 9
    Demark-Wahnefried W, Strigo T, Catoe K, Conaway M, Brunetti M, Rimer BK, et al. Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening. Urology 1995; 46: 34651.
  • 10
    Budenholzer BR. Prostate-specific antigen testing to screen for prostate cancer. J Fam Pract 1995; 41: 2708.
  • 11
    Whittemore AS, Lele C, Friedman GD, Stamey T, Vogelman JH, Orentreich N. Prostate-specific antigen as predictor of prostate cancer in black and white men. J Natl Cancer Inst 1995; 87: 35460.
  • 12
    U.S. Congress, Office of Technology Assessment. Costs and effectiveness of prostate cancer screening in elderly men, 1995. Washington, DC: U.S. Government Printing Office, 1995.
  • 13
    Friedman GD, Hiatt RA, Quesenberry CP, Selby JV. Case-control study of screening for prostate cancer by digital rectal examination. Lancet 1991; 337: 15269.
  • 14
    Gerber GS, Thompson IM, Thistad R, Chodak GW. Disease-specific survival following routine cancer screening by digital rectal examination. JAMA 1993; 269: 614.
  • 15
    Gohagen JK, Prorok PC, Kramer BS, Cornett JE. Prostate cancer screening in the prostate, lung, colorectal, and ovarian cancer screening trial of the National Cancer Institute. J Urol 1994; 152: 19059.
  • 16
    Woolf S. Screening for prostate cancer with prostate-specific antigen. N Engl J Med 1995; 333: 14015.
  • 17
    Khran M, Mahoney J, Eckman M, Trachtenberg J, Paulker S, Detsky A. Screening for prostate cancer: a decision-analytic view. JAMA 1994; 272: 77380.
  • 18
    Stewart A, Ware JE. Measuring functioning and well-being: the Medical Outcomes Study, 1992. Durham, NC: Duke University Press, 1992.
  • 19
    Health Outcomes Institute. Health status questionnaire 2.0: user guide. Boston, MA: New England Medical Center, 1993.
  • 20
    Barry MJ, Fowler FJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992; 148: 154957.
  • 21
    Barry MJ, Fowler FJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL. Correlation of the AUA symptom index with self-administered versions of the Madsen-Iverson, Boyarsky and Maine medical assessment program indexes. J Urol 1992; 148: 155863.
  • 22
    O'Leary MP, Barry MJ, Fowler FJ. Hard measures of subjective outcomes: validating symptom indexes in urology. J Urol 1992; 148: 15468.
  • 23
    Strechler VI, Rosenstock IM. The health belief model. In: GlanzK, LewisFM, RomerBK, editors. Health behavior and health education, 2nd ed. San Francisco: Jossey-Bass, 1997: 4159.
  • 24
    JabineTB, StrafML, TanurJM, TourangeauR, editors. Cognitive aspects of survey methodology: bulding a bridge between disciplines. Washington, DC: National Academy Press, 1984.
  • 25
    Myers RE, Wolf TA. McKee L, McGrory G, Burgh DY, Nelson G, et al. Factors associated with intention to undergo annual prostate cancer screening among African-American men in Philadelphia. Cancer 1996;78: 4719.
  • 26
    Smith GE, DeHaven MJ, Grundig JP, Wilson GR. African-American males and prostate cancer: assessing knowledge levels in the community. J Natl Med Assoc 1997; 89: 38791.
  • 27
    Demers RY, Swanson GM, Weiss LK, Tsing-Ying K. Increasing incidence of cancer of the prostate: the experience of black and white men in the Detroit metropolitan area. Arch Intern Med 1994; 154: 12116.
  • 28
    Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA 1995; 273: 54852.
  • 29
    Williams RB, Boles M, Johnson RE. Use of prostate-specific antigen for prostate cancer screening in primary care practice. Arch Fam Med 1995; 4: 3115.
  • 30
    Lane DS, Burg MA. Breast cancer screening: changing physician practices and specialty variation. N Y State J Med 1990; 90: 28892.